Regulation of transcriptional coactivator p300 by posttranslational modification
Regulation of transcriptional coactivator p300 by posttranslational modification
批准号:
RGPIN-2017-03734
负责人:
Li, Qiao
金额:
$2.91万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31
中文摘要
转录辅激活子p300具有内在的组蛋白乙酰转移酶(HAT)活性,对许多细胞过程都很重要。因此,严格控制p300对于确保位点特异性组蛋白乙酰化和基因调控至关重要。我们之前已经确定p300受翻译后修饰和不同细胞分布的动态调控。我们是第一个证明p300是由细胞质蛋白酶体系统调节的。此外,我们已经确定Akt/protein kinase B是p300的正调控因子,而蛋白磷酸酶2A (PP2A)的B563调控亚基是负调控因子。我们的工作为细胞运输和空间再分配如何控制p300的蛋白质稳定性和转录活性提供了新的见解。最近,我们发现p300在肌源性分化过程中以一种谱系特异性的方式受到调节。因此,我们打算利用我们的发现来定义与成肌细胞分化相关的谱系特异性p300调控的分子机制。******我们假设可逆磷酸化蛋白在控制p300活性中发挥关键作用,进而在成肌细胞分化过程中调节p300的功能,并提出在成肌细胞分化过程中定义B563调节亚基、Akt和其他激酶与p300的功能相互作用。我们将调查p300磷酸化谱,并通过功能增益和功能丧失的方法描述p300通过可逆磷酸化的调节。我们将产生模拟候选位点磷酸化的突变体,并产生针对位点特异性磷酸化的抗体,以研究可逆磷酸化对p300稳定性和转录活性的影响。我们的目标是确定翻译后修饰介导的p300调控的分子基础及其对p300在基因转录方面作为HAT、支架或染色质桥的功能的影响。我们将定义与细胞分化相关的不同信号通路和p300调控的分子机制。我们的长期目标是确定这些调节机制如何控制p300依赖的基因表达,从细胞内运输,蛋白质周转到转录激活,并以网络生物学的方式确定p300功能的分子基础。******这个研究项目是建立在我们最近的发现之上的,并以p300为基础,p300对体内不同的细胞过程和骨骼肌形成至关重要。许多HQP将通过我们已证明的跟踪记录所显示的拟议研究进行培训,因此,他们将做好准备,成功地导航到自己的职业道路,并为我们的研究领域和不同的加拿大组织做出重大贡献。
英文摘要
The transcriptional coactivator p300 possess an intrinsic histone acetyltransferase (HAT) activity and is important for many cellular processes. A tight control of p300 is therefore critical to ensure locus-specific histone acetylation and gene regulation. We have established previously that p300 is dynamically regulated by posttranslational modification and distinct cellular distribution. We are the first to show that p300 is modulated by the cytoplasmic proteasome system. In addition, we have established that Akt/protein kinase B is a positive regulator of p300, while the B563 regulatory subunit of protein phosphatase 2A (PP2A) is a negative regulator. Our works have provided novel insights into how cellular trafficking and spatial redistribution control the protein stability and transcriptional activity of p300. Recently, we found that p300 is regulated in a lineage specific manner during myogenic differentiation. As such, we intend to leverage our findings to define the molecular mechanisms underlying lineage-specific p300 regulation associated with myoblast differentiation. ******We hypothesize that reversible phosphorylaton plays critical roles in the control of p300 activity, which in turn modulates p300 function during myoblast differentiation, and propose to define the functional interactions of the B563 regulatory subunit, Akt, and additional kinases with p300, in milieu of myoblast differentiation. We will survey p300 phosphorylation profiles and delineate the regulation of p300 by reversible phosphorylation with gain- and loss-of-function approaches. We will generate mutants that mimic candidate site phosphorylation and produce antibodies against site-specific phosphorylation to study the impact of reversible phosphorylation on p300 stability and transcriptional activity. Our goals are to determine the molecular basis for posttranslational modification-mediated p300 regulation and their consequences on the function of p300 as a HAT, a scaffold or a bridge on chromatin with respect to gene transcription. We will define the molecular mechanisms underlying different signaling pathways and p300 regulation pertinent to cellular differentiation. Our long term goals are to determine how these regulatory mechanisms control p300-dependent gene expression from intracellular trafficking, protein turnover to transcriptional activation, and to determine the molecular basis for p300 function in a network biology fashion. ******This research program is founded upon our recent findings and anchored on the p300 which is essential for different cellular processes and skeletal myogenesis in vivo. Many HQP will be trained through the proposed research as shown by our proven track record, and as a result, they will be well equipped to navigate into their own career path successfully and to contribute to our research field and different Canadian organizations significantly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of transcriptional coactivator p300 by posttranslational modification
-
批准号:RGPIN-2017-03734
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$5.83万
-
财政年份:2021
-
负责人:Li, Qiao
-
依托单位:
Regulation of transcriptional coactivator p300 by posttranslational modification
-
批准号:RGPIN-2017-03734
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.91万
-
财政年份:2020
-
负责人:Li, Qiao
-
依托单位:
Regulation of transcriptional coactivator p300 by posttranslational modification
-
批准号:RGPIN-2017-03734
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.91万
-
财政年份:2018
-
负责人:Li, Qiao
-
依托单位:
Regulation of transcriptional coactivator p300 by posttranslational modification
-
批准号:RGPIN-2017-03734
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.91万
-
财政年份:2017
-
负责人:Li, Qiao
-
依托单位:
Effects of acetylation on the function of a transcriptional co-activator
-
批准号:250174-2012
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.89万
-
财政年份:2015
-
负责人:Li, Qiao
-
依托单位:
Effects of acetylation on the function of a transcriptional co-activator
-
批准号:250174-2012
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.89万
-
财政年份:2014
-
负责人:Li, Qiao
-
依托单位:
Effects of acetylation on the function of a transcriptional co-activator
-
批准号:250174-2012
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.89万
-
财政年份:2013
-
负责人:Li, Qiao
-
依托单位:
Effects of acetylation on the function of a transcriptional co-activator
-
批准号:250174-2012
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.89万
-
财政年份:2012
-
负责人:Li, Qiao
-
依托单位:
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
-
批准号:250174-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:Li, Qiao
-
依托单位:
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
-
批准号:250174-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.1万
-
财政年份:2009
-
负责人:Li, Qiao
-
依托单位:
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
-
批准号:250174-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.1万
-
财政年份:2008
-
负责人:Li, Qiao
-
依托单位:
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
-
批准号:250174-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.1万
-
财政年份:2007
-
负责人:Li, Qiao
-
依托单位:
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
-
批准号:250174-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.1万
-
财政年份:2006
-
负责人:Li, Qiao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
辅酶A类代谢中间产物参与组蛋白表观遗传修饰调控肝细胞代谢网络对高油脂营养应答的机制研究
-
批准号:91957110
-
项目类别:重大研究计划
-
资助金额:83.0万元
-
批准年份:2019
-
负责人:王玉刚
-
依托单位:
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
-
批准号:60871014
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:王进科
-
依托单位:
新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
-
批准号:30801325
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:张争
-
依托单位: